Archer is now part of IDT, bringing the future of precision oncology to cancer care. The transaction was completed December 2022. Learn more here.

Webinar: Advanced comprehensive genomic panels for myeloid neoplasms

Implementation and practice of Anchored Multiplex PCR (AMP™) technology at Genpath Oncology
February 21, 2023, 1 pm EST

The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.

Our products and services

Research
Products

Investigational Liquid-biopsy Based Cancer Recurrence Detection

Clinical Research Services

Co-development Services

We aim to address barriers to bringing precision oncology to patients, anywhere

We are global

We partner with leading
global pharmaceutical
companies

We provide expansive
access

Follow the Science

Find out more about us and stay in touch